Report: Vaccination against COVID-19 Slows in Underdeveloped Nations

"Wall Street  Journal", a US daily newspaper, revealed that the efforts exerted to vaccinate peoples of the poor underdeveloped nations across the globe against the Coronavirus ( known also as COVID-19)have slowed significantly.

Shortage of vaccines led to a worrying increase in infection with the Coronavirus during the last few weeks.

Officials of COVAX initiative said that they are planning now to reduce the number of doses intended to be delivered to the poor nations from 240 million doses to 145 million by the end of May.

It is worth noting that COVAX is an initiative funded by the WORLD Health Organization (WHO)  and the developed nations to ship free doses of the anti-Corona vaccines to 92 poor countries.

These officials revealed that the shortage of doses related to India's decision to cease delivering doses to the initiative due high rates of infections in India itself.

India was the main supplier of the anti-Corona vaccines to the initiative.

The US newspaper warns that the shortage in vaccination in the poor nations widens the gap that secludes the poor and rich in the world.

It indicates that 200 million doses were distributed in the United States of America (USA) alone.

But COVAX has offered only less than 41 million doses of two billion planned doses by the end of the standing year.

However, experts stress that the slow distribution of vaccines in the underdeveloped countries may cause problems in the other parts of the world.

Epidemiologists     warn that  failure in vaccinating population in the poor countries may lead to leave huge numbers of the deadly virus which mat mutate and then transmit into the developed nations.

The World Health Organization has previously criticized the unjust policies of distribution the vaccines across the world.

The UN organization pointed out that 76% of the total numbers of the anti-Corona vaccines have been stored in 10 developed countries.

WHO Director-General Tedros Adhnom Ghebreyesus said that "vaccine nationalism" could cost the global economy up to $ 9.2 trillion.